Close

Jump to:

  • Navigation
  • Content
  • Footer
Omni Pet hero image

Omni Pet

Follow

Award-winning plant based food for pooches with proven health benefits. Co-founded by a vet, VC-backed.

188%
 - 
Funded 27 Feb 2023
£400,004 target
£758,314 from 382 investors
More
Less

Business overview

Location London, United Kingdom
Social media
Website omni.pet/
Sectors Food & Beverage Non-Digital B2C
Company number 13024483
Incorporation date 16 Nov 2020
More
Less

Investment summary

Type Equity
Valuation (pre-money) £6.5M
Equity offered 10.37%
Share price £5.51
Tax relief

EIS

More
Less

Business highlights

  • £650K sales '22, £70K+ MR in Q4, 70% subscription sales*
  • Recommended by 90% of veterinary professionals
  • 34% of dog owners are looking to feed them plant based meals
  • Peer reviewed study shows health benefits of the Omni diet
More
Less

Key features

  • Secondary Market
  • Nominee investment min. £11.02 +
  • Direct investment min. £10,000.00 +
  • Idea
  • Key Information
  • Investor Perks
  • Team
  • Updates
  • Investors 382
  • Discussion
  • Documents

Idea

Introduction

Omni’s award-winning proprietary plant-powered formulation gives dogs a nutritionally complete diet with proven health benefits. Plus, over half of dogs trialled showed preference for it over their usual meat-based meal so it tastes good, too!

Vet Dr Guy Sandelowsky co-founded Omni after his dog, Bondie got mouth cancer. Following 9 months developing a protein-led formula with Associate Veterinary Professor Dr. Mike Davies, Omni was trialled with 100 dog guardians feeding meat-based diets with 91% positive feedback, and launched in 2021.

Independent studies have found dogs fed plant-based diets live up to 18 months longer than those eating meat, as well as visiting the vet less & needing fewer medications.

As feeding a dog a typical meat diet creates the same carbon emissions as driving a Land Cruiser SUV all year round, switching to plant-based can have a hugely positive planetary impact, too.

We’re raising to scale D2C, launch new products, expand into retail & enter new markets.

Substantial accomplishments to date

In 2021, we soft launched in May, developing, with a subscription model and larger food packs live on our site from September.

Since then Omni has:

- Averaged 30% month on month growth*

- Retained over 50% of customers (post-trial) after 1 year. This is 2x higher than the average retention rate for pet products.

- Delivered over 500k meals

- Achieved gross revenue of £650k in 2022*

- Published a peer reviewed paper, which demonstrates the health benefits of Omni.

- Had Omni recommended by 9 out of 10 veterinary professionals.

- Launched on Amazon and approached by Walmart in the US to sell Omni

- Developed a range of plant-based dog snacks, which we plan to launch in Q1.

- Been featured in The Guardian, the Financial Times, Sky news, The BBC, The grocer, and the Evening Standard.

- Delivered strategic marketing and brand building through social channels, Google and a community of influencers.

- Won a World Finance Innovation award 2022.

Monetisation strategy

We launched on a DTC model, through our eCommerce website, which allowed us to scale without additional outlay. We've nurtured our site and community of customers, and grown to an average monthly revenue of £70k in Q4 2022*.

We have an engaged base of 13k+ social followers and a mailing list of 11k, as well as a thriving customer loyalty rewards programme.

Over 70% of our sales are from subscription, which we'll continue to build on.

We're now stocked on Amazon to reach a wider audience, and are looking to further expand into retail this year as well as exploring leading pet retailers for our meals and soon-to-be-launched snack range.

*Based on unaudited management accounts.

Use of proceeds

Our focus will remain D2C, as this is already a proven success, and we want to continue our direct relationship with subscribers, increasing numbers and converting new customers.

Alongside this, we plan to use part of our funds to promote & develop our new product ranges and explore new markets:

- 61% Marketing - Targeted social, Google and influencer campaigns for D2C, as well as Amazon advertising spend and retail channels.

- 18% New product launch of our plant-based snack range.

- 10% Team hire to support our German expansion, with customer service support and digital marketer hires.

- 7% Channel expansion into retail

- 4% Internationalisation, initial set up costs for German market

Key Information

Outstanding ASAs

The company has a number of outstanding Advanced Subscription Agreements (ASAs) totalling £665,000, which may convert to equity as part of or after this round and dilute existing shareholders:

All of the ASAs have the following key terms:

Discount: 20%
Longstop date: 18 months from the date of the agreement (meaning that the longstop dates will be reached between 28th April 2023 and 1st July 2023 depending on the date of the ASA)
Valuation Cap: £5,000,000

In addition, Atomico, Kale United and Foodhack (totalling £115,000 of investment) have the following terms for conversion:

Conversion trigger: (1) Financing Round (a new equity funding round of £500,000 or more), or (2) Sale or IPO
Conversion price: a discount of 20% of the Subscription Price (being the lowest price per share in the Financing Round) or the Exit Price (being the price per share pursuant to such Sale or the price per share issued pursuant to such IPO) as applicable
Share class: Ordinary shares

Conversion trigger: (3) Longstop Date or (4) Dissolution Event
Conversion price: a price per share based on a £5,000,000 valuation cap.
Share class: Ordinary shares

Purple Orange Ventures, Shio Equity, Trellis Road and ANDA4 (totalling £550,000 of investment) have the following terms for conversion:

Conversion trigger (1) Financing round (a new equity funding round of £500,000 or more) (2) Sale or IPO
Conversion price: the lower of (i) a discount of 20% of the Subscription Price (being the lowest price per share in the Financing Round) or the Exit Price (being the price per share pursuant to such Sale or the price per share issued pursuant to such IPO) or (ii) a price per share based on a post-money valuation of £5,000,000
Share class: Ordinary shares

Investor Perks

Please note that any discounts, rewards and/or offers listed by a company in its campaign are subject to the terms and conditions applied by that company. It is the company’s responsibility to honour such discounts, rewards and/or offers and Seedrs does not take any responsibility for them.

Open an account to get access to the team members of Omni Pet

Sign up

Already have an account? Log in

To comply with financial regulations, we can only show full campaign details to registered users.

Only shareholders can access this page

If you successfully purchase a share lot of this business, you will be granted access.

Buy shares

Only shareholders can access this page

If you successfully purchase a share lot of this business, you will be granted access.

Buy shares

Only shareholders can access this page

If you successfully purchase a share lot of this business, you will be granted access.

Buy shares

Only shareholders can access this page

If you successfully purchase a share lot of this business, you will be granted access.

Buy shares

Share on:

Investing involves risks, including loss of capital, illiquidity, lack of dividends and dilution, and should be done only as part of a diversified portfolio. Please read the Risk Warnings before investing. Investments should only be made by investors who understand these risks. Tax treatment depends on individual circumstances and is subject to change in future.

This campaign for Omni Pet has been approved by Seedrs Limited (trading as Republic Europe) ("Republic Europe", "us" or "we"), as of 20 January 2023 as a financial promotion. Republic Europe is authorised and regulated by the Financial Conduct Authority with firm reference number 550317. In approving this campaign, Republic Europe has concluded that the information, taken as a whole, is "fair, clear and not misleading." This means that for factual statements we have reviewed evidence of their accuracy, and that for aspirational statements we believe they are phrased appropriately in light of their speculative nature. You should note that in the case of factual statements, the evidence we review is provided by the business, and we do not audit it, which means that we may not be able to identify forged or altered evidence. You should further note that in the case of aspirational statements, the nature of the type of businesses presented on the Republic Europe platform is such that they are likely to have high ambitions, and we may approve statements that convey those ambitions even where we do not believe, or we do not have a view on whether it is likely, that they will be fully realised. The pre-money valuation and investment sought in the campaign are those set by the business: they are not reviewed or established by us, and the valuation is not an independent view of what the business is worth. Given the nature and type of businesses presented on the Republic Europe platform, it is possible that the business has very little cash remaining prior to receiving this investment, and the investment sought may be necessary for the business's on-going existence.

Republic Europe does not make investment recommendations to you. No communications from Republic Europe, through this website or any other medium, should be construed as an investment recommendation. Further, nothing on this website shall be considered an offer to sell, or a solicitation of an offer to buy, any security to any person in any jurisdiction to whom or in which such offer, solicitation or sale is unlawful. Republic Europe does not provide legal, financial or tax advice of any kind. If you have any questions with respect to legal, financial or tax matters relevant to your interactions with Republic Europe, you should consult a professional adviser.

Tax Relief (SEIS)

This business is eligible for SEIS relief - providing qualifying investors with income tax relief of 50% of their investment and certain other tax reliefs. Tax treatment depends on individual circumstances and is subject to change in future. Click to learn more.

Tax Relief (EIS)

This business is eligible for EIS relief - providing qualifying investors with income tax relief of 30% of their investment and certain other tax reliefs. Tax treatment depends on individual circumstances and is subject to change in future. Click to learn more.

Valuation (pre-money)

Valuation rounded from £6,509,690

This is the fully-diluted pre-money valuation of the business (i.e. before the new investment comes in and including issued options and other equity interests). In contrast, the post-money valuation is based on inclusion of the new investment in the value.

It is calculated as the pre-money valuation plus the amount of new investment. e.g. If Company A is ascribed a pre-money valuation of £1,200,000 by prospective investors investing £300,000, its post-money valuation is £1,500,000.

The investee business is responsible for setting its own valuation, it has not been prescribed by Seedrs.

Pitch type

Investing in a regular equity campaign is the simplest and most common way to invest in a startup. You decide which business you want to invest in, and if the campaign hits its funding target then you will become one of their shareholders. As the company becomes more valuable, so do your shares; allowing you the opportunity to share in the future success of the business.

Learn more about pitch type on Seedrs

Equity Offered

The equity offered is the percentage of the company’s shares being issued in return for the amount of investment raised.

When the amount raised is less than 100%, the equity offered is based on the target raise. Once the company has raised over 100% it is based on the total raised.

In some scenarios, entrepreneurs may accept additional direct investment after closing their Seedrs campaign. Provided this is within 6 months of the closing and on the same terms, we do not typically offer pre-emption rights on that extra investment (where you have the opportunity to invest again to maintain your percentage shareholding).

Learn more about investing and pre-emption rights.

Nominee investment

This shows if you are able to choose, when making an investment, that you be represented by, and your shareholding be managed by, the Nominee investment.

Find out more

Custodian

If you invest in this Campaign, Seedrs will act as Custodian rather than provide our standard nominee service. This is due to the fact that the business is not directly involved in the share sale and Seedrs will not benefit from any rights under a shareholder agreement. As a result, Seedrs will handle administrative tasks as we do normally, but you will not have information or voting rights, updates from the business, preemption on future fundraising, or ongoing support about business trading activity.

Learn more about Custodian here

Secondary market

This shows if the business has opted-in or opted-out of allowing its shares to be bought and sold on the secondary market.

Find out more

Direct investment

This is an option to invest and hold shares 'directly' in the company (rather than via the Nominee investment). This option is only available to those investing over the threshold amount, which is determined by the fundraising company.

If you choose to hold your shares directly, you will be responsible for any contractual or administrative arrangements with the company you are investing in.

Find out more

Payment options

We are not able to accept card payments for investments into this sector. You can pay for your investment by creating a bank transfer, using funds in your investment account or create a Pay by Bank payment. Your investment will only be completed once the funds have reached our account.

Business Involvement

This Campaign offers shares for sale in business that is not directly involved in this Campaign or the sale. As a result, the Campaign and post-investment experience, including investor rights, will differ from a business-led campaign on Seedrs. Most notably, the business will not engage with investors in the discussion forums both during and after the sale or provide any updates to investors.

Learn more here

Payment options

We are not able to accept Pay by Bank payments for investments into this sector. You can pay for your investment with a card payment, by creating a bank transfer or by using funds in your investment account. Your investment will only be completed once the funds have reached our account.

Drawdowns

This campaign offers the ability to pay for an investment by drawdowns.

Security Token

A security token is a digital asset that represents ownership or other rights. It is a digital form of traditional investments. In the future, you may be able to trade your investment through compatible exchanges.

Warning

You are following a link outside of europe.republic.com.

None of the information in constitutes part of the campaign and it has not been approved or reviewed by Seedrs.

ContinueCancel